Sensei biotherapeutics to participate in canaccord genuity's horizons in oncology virtual conference

Boston, april 09, 2024 (globe newswire) --  sensei biotherapeutics, inc. (nasdaq: snse), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that company management will participate in a panel titled ‘kras and vista - better approaches for key targets' at canaccord genuity's horizons in oncology virtual conference on monday, april 15th at 2:00 p.m. et.
SNSE Ratings Summary
SNSE Quant Ranking